Dr Charles Eugne Chambers, MD | |
1125 May St, Suite 202, Hood River, OR 97031 | |
(541) 387-8940 | |
(541) 387-8908 |
Full Name | Dr Charles Eugne Chambers |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 1125 May St, Hood River, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831144187 | NPI | - | NPPES |
287488 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD23022 (Oregon) | Primary |
Entity Name | Legacy Clinics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
This week, three patients in the United States received the first implants of the Boston Scientific Corporation WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device.
› Verified 5 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1255429338 PECOS PAC ID: 7315856010 Enrollment ID: O20061104000324 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
This week, three patients in the United States received the first implants of the Boston Scientific Corporation WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Charles Eugne Chambers, MD Po Box 3390, Portland, OR 97208-3390 Ph: () - | Dr Charles Eugne Chambers, MD 1125 May St, Suite 202, Hood River, OR 97031 Ph: (541) 387-8940 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.
Baylor Research Institute, the research arm of the Baylor Scott & White Health, announced that it has signed an agreement with Swedish Orphan Biovitrum AB (Sobi) to non-exclusively license Baylor's patents pertaining to the treatment of Systemic Onset Juvenile Idiopathic Arthritis (SJIA or SOJIA) using interleukin-1 (IL-1) beta antagonists.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
This week, three patients in the United States received the first implants of the Boston Scientific Corporation WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device.
› Verified 5 days ago
Dr. Robin B Henson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 917 11th St, Suite 200, Hood River, OR 97031 Phone: 541-387-8940 | |
Heather Mary Sponsel Lytle, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1125 May St, Ste 202, Hood River, OR 97031 Phone: 541-387-8940 | |
Elaine Ramsey Adsit, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1631 Woods Ct Ste 103, Hood River, OR 97031 Phone: 541-387-0244 Fax: 541-436-4766 | |
Dr. Lara Ann Weyl, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1125 May St, Ste 202, Hood River, OR 97031 Phone: 541-387-8940 Fax: 541-387-8908 | |
George Marion Bailey, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 810 13th St, Hood River, OR 97031 Phone: 541-387-6464 Fax: 541-386-9322 |